Endocrinology and Metabolism

Original Articles

Mineral, Bone & Muscle
Comparison of Two DXA Systems, Hologic Horizon W and GE Lunar Prodigy, for Assessing Body Composition in Healthy Korean Adults: Seung Shin Park, Soo Lim, Hoyoun Kim, Kyoung Min Kim; Endocrinol Metab. 2021;36(6):1219-1231. Published online December 16, 2021; DOI: https://doi.org/10.3803/EnM.2021.1274

11,082 View
220 Download
17 Web of Science
19 Crossref

Abstract PDF Supplementary Material PubReader ePub

Background
Dual-energy X-ray absorptiometry (DXA) is the most widely used method for evaluating muscle masses. The aim of this study was to investigate the agreement between muscle mass values assessed by two different DXA systems.
Methods
Forty healthy participants (20 men, 20 women; age range, 23 to 71 years) were enrolled. Total and regional body compositional values for fat and lean masses were measured consecutively with two DXA machines, Hologic Horizon and GE Lunar Prodigy. Appendicular lean mass (ALM) was calculated as the sum of the lean mass of four limbs.
Results
In both sexes, the ALM values measured by the GE Lunar Prodigy (24.8±4.3 kg in men, 15.8±2.9 kg in women) were significantly higher than those assessed by Hologic Horizon (23.0±4.0 kg in men, 14.8±3.2 kg in women). Furthermore, BMI values or body fat (%), either extremely higher or lower levels, contributed greater differences between two systems. Bland-Altman analyses revealed a significant bias between ALM values assessed by the two systems. Linear regression analyses were performed to develop equations to adjust for systematic differences (men: Horizon ALM [kg]=0.915×Lunar Prodigy ALM [kg]+0.322, R²=0.956; women: Horizon ALM [kg]=1.066×Lunar Prodigy ALM [kg]–2.064, R²=0.952).
Conclusion
Although measurements of body composition including muscle mass by the two DXA systems correlated strongly, significant differences were observed. Calibration equations should enable mutual conversion between different DXA systems.

Citations

Citations to this article as recorded by

Development and validation of a phase-sensitive bioelectrical equation for estimating skeletal muscle mass using DXA as reference
Francesco Campa, Alessandro Sampieri, Gioi Spinello, Tatiana Moro, Antonio Paoli
Nutrition, Metabolism and Cardiovascular Diseases.2026; 36(1): 104281. CrossRef
Prevalence of low muscle mass and its association with orthostatic hypotension and related symptoms in Parkinson’s disease
Seohee Choi, Ryul Kim, Soonwook Kwon, Jin-Sun Jun, Kyeongho Byun, Nyeonju Kang, Kiwon Park, Jee-Young Lee, Beomseok Jeon
npj Parkinson's Disease.2026;[Epub] CrossRef
Advancing sarcopenia assessment with wearable and app-based technology: a scoping review
Ayush Mehra, Justo Perez, Jessica L. Krok-Schoen, Roberto M. Benzo, Colleen K. Spees, Shang-Jui Wang, Steven K. Clinton, Stefan A. Czerwinski, Brett S. Nickerson
The Journal of nutrition, health and aging.2026; 30(5): 100824. CrossRef
Development of an Algorithm to Predict Appendicular Lean Mass Index From Regional Spine and Hip Dxa Scans
Krista Rossum, Mackenzie R. Alexiuk, Clara Bohm, William D. Leslie, Navdeep Tangri
Journal of Clinical Densitometry.2025; 28(2): 101560. CrossRef
Comparing digital anthropometrics from mobile applications to reference methods: a scoping review
Irismar Gonçalves Almeida da Encarnação, Matheus Santos Cerqueira, Paulo Henrique Ribeiro Fernandes Almeida, Cláudia Eliza Patrocínio de Oliveira, Analiza Mónica Lopes de Almeida Silva, Diego Augusto Santos Silva, Steven B. Heymsfield, Osvaldo Costa Morei
European Journal of Clinical Nutrition.2025; 79(9): 809. CrossRef
Sarcopenia, Muscle Mass and Protein Intake in Adults Older Than 65 Years After Earlier Bariatric Surgery
Gabriël Eksteen, Tim Vanuytsel, Roman Vangoitsenhoven, Ann Mertens, Matthias Lannoo, Ellen De Leus, Bart Van der Schueren, Christophe Matthys
Journal of Cachexia, Sarcopenia and Muscle.2025;[Epub] CrossRef
Ultrasound-Derived Skinfolds in Anthropometric Predictive Equations Overestimate Fat Mass: A Validation Study Using a Four-Component Model
Giuseppe Cerullo, Martino V. Franchi, Alessandro Sampieri, Francesco Campa, Antonio Paoli
Nutrients.2025; 17(11): 1881. CrossRef
Evaluating the Accuracy and Clinical Utility of Bioelectrical Impedance Analysis (BIA) Devices for Body Composition Measurements in Clinical Practice: Comparison of Four Types of BIA Equipment and Dual-Energy X-ray Absorptiometry
So Youn LEE, Hwayeon SUN, Sung Hwan BAE, Ju Yeon SON, Byungwook YOO
Korean Journal of Health Promotion.2025; 25(2): 50. CrossRef
Segmental fat-free mass and lean soft mass: a comparative study with dual X-ray absorptiometry (DXA), bioelectrical impedance analysis (BIA) and anthropometry and development of anthropometric prediction models
Nicolás Baglietto, Mario Albaladejo-Saura, Francisco Esparza-Ros, Malek Mecherques-Carini, Raquel Vaquero-Cristóbal
Journal of the International Society of Sports Nutrition.2025;[Epub] CrossRef
Body mass, linear growth, and body composition before and after the introduction of elexacaftor/tezacaftor/ivacaftor among children and adults with cystic fibrosis
Karlen Bader-Larsen, Bibi Uhre Nielsen, Esben Henriksen, Thomas Bryrup, Christian Leo-Hansen, Inger Hee Mabuza Mathiesen, Daniel Faurholt-Jepsen, Tavs Qvist, Peter Oturai, Bente Langdahl, Majbritt Jeppesen, Hanne Vebert Olsen, Tacjana Pressler, Marianne S
Clinical Nutrition.2025; 54: 132. CrossRef
Birth Characteristics and Bone Mineral Density and Content in Young Adults: The HUNT Study, Norway
H. T. Holltrø, T. I. L. Nilsen, B. Schei, J. Horn, K. Holvik, A. K. N. Daltveit, E. M. Dennison, N. C. Harvey, A. Langhammer, M. Hoff
Calcified Tissue International.2025;[Epub] CrossRef
Glycaemic Response to a Nut-Enriched Diet in Asian Chinese Adults with Normal or High Glycaemia: The Tū Ora RCT
Ivana R. Sequeira-Bisson, Louise W. Lu, Marta P. Silvestre, Lindsay D. Plank, Nikki Middleditch, Alejandra Acevedo-Fani, Amber Parry-Strong, Kieren G. Hollingsworth, Alexander Tups, Jennifer L. Miles-Chan, Jeremy D. Krebs, Meika Foster, Sally D. Poppitt
Nutrients.2024; 16(13): 2103. CrossRef
The usefulness of total body protein mass models for adolescent athletes
Analiza M. Silva, Francesco Campa, Luís B. Sardinha
Frontiers in Nutrition.2024;[Epub] CrossRef
Standardization of body composition parameters between GE Lunar iDXA and Hologic Horizon A and their clinical impact
Colin Vendrami, Guillaume Gatineau, Elena Gonzalez Rodriguez, Olivier Lamy, Didier Hans, Enisa Shevroja
JBMR Plus.2024;[Epub] CrossRef
Impaired Muscle Parameters in Individuals With Premature Ovarian Insufficiency: A Pilot Study
Navira Samad, Wei Ling Chiu, Hanh H Nguyen, Zhong X Lu, Margaret Zacharin, Peter R Ebeling, Helena Teede, David Scott, Frances Milat, Amanda J Vincent
Journal of the Endocrine Society.2024;[Epub] CrossRef
Comparison of bioelectrical impedance analysis and dual-energy X-ray absorptiometry for the diagnosis of sarcopenia in the older adults with metabolic syndrome: equipment-specific equation development
Younji Kim, Jaewon Beom, Sang Yoon Lee, Hak Chul Jang, Keewon Kim, Miji Kim, Ga Yang Shim, Chang Won Won, Jae-Young Lim
Aging Clinical and Experimental Research.2024;[Epub] CrossRef
Total and regional appendicular skeletal muscle mass prediction from dual-energy X-ray absorptiometry body composition models
Cassidy McCarthy, Grant M. Tinsley, Anja Bosy-Westphal, Manfred J. Müller, John Shepherd, Dympna Gallagher, Steven B. Heymsfield
Scientific Reports.2023;[Epub] CrossRef
Cross-Calibration of iDXA and pQCT Scanners at Rural and Urban Research Sites in The Gambia, West Africa
Mícheál Ó Breasail, Ramatoulie Janha, Ayse Zengin, Camille Pearse, Landing Jarjou, Ann Prentice, Kate A. Ward
Calcified Tissue International.2023; 112(5): 573. CrossRef
Estimation of Absolute and Relative Body Fat Content Using Noninvasive Surrogates: Can DXA Be Bypassed?
David J. Greenblatt, Christopher D. Bruno, Jerold S. Harmatz, Bess Dawson‐Hughes, Qingchen Zhang, Chunhui Li, Christina R. Chow
The Journal of Clinical Pharmacology.2023;[Epub] CrossRef

Endocrine Research
Effects of Glucagon-Like Peptide-1 Analogue and Fibroblast Growth Factor 21 Combination on the Atherosclerosis-Related Process in a Type 2 Diabetes Mouse Model: Jin Hee Kim, Gha Young Lee, Hyo Jin Maeng, Hoyoun Kim, Jae Hyun Bae, Kyoung Min Kim, Soo Lim; Endocrinol Metab. 2021;36(1):157-170. Published online February 24, 2021; DOI: https://doi.org/10.3803/EnM.2020.781

12,492 View
214 Download
22 Web of Science
22 Crossref

Abstract PDF Supplementary Material PubReader ePub

Background
Glucagon-like peptide-1 (GLP-1) analogues regulate glucose homeostasis and have anti-inflammatory properties, but cause gastrointestinal side effects. The fibroblast growth factor 21 (FGF21) is a hormonal regulator of lipid and glucose metabolism that has poor pharmacokinetic properties, including a short half-life. To overcome these limitations, we investigated the effect of a low-dose combination of a GLP-1 analogue and FGF21 on atherosclerosis-related molecular pathways.
Methods
C57BL/6J mice were fed a high-fat diet for 30 weeks followed by an atherogenic diet for 10 weeks and were divided into four groups: control (saline), liraglutide (0.3 mg/kg/day), FGF21 (5 mg/kg/day), and low-dose combination treatment with liraglutide (0.1 mg/kg/day) and FGF21 (2.5 mg/kg/day) (n=6/group) for 6 weeks. The effects of each treatment on various atherogenesisrelated pathways were assessed.
Results
Liraglutide, FGF21, and their low-dose combination significantly reduced atheromatous plaque in aorta, decreased weight, glucose, and leptin levels, and increased adiponectin levels. The combination treatment upregulated the hepatic uncoupling protein-1 (UCP1) and Akt1 mRNAs compared with controls. Matric mentalloproteinase-9 (MMP-9), monocyte chemoattractant protein-1 (MCP-1), and intercellular adhesion molecule-1 (ICAM-1) were downregulated and phosphorylated Akt (p-Akt) and phosphorylated extracellular signal-regulated kinase (p-ERK) were upregulated in liver of the liraglutide-alone and combination-treatment groups. The combination therapy also significantly decreased the proliferation of vascular smooth muscle cells. Caspase-3 was increased, whereas MMP-9, ICAM-1, p-Akt, and p-ERK1/2 were downregulated in the liraglutide-alone and combination-treatment groups.
Conclusion
Administration of a low-dose GLP-1 analogue and FGF21 combination exerts beneficial effects on critical pathways related to atherosclerosis, suggesting the synergism of the two compounds.

Citations

Citations to this article as recorded by

Clonal Hematopoiesis of Indeterminate Potential and Atrial Fibrillation: Insights into Pathophysiology and Clinical Implications
Paschalis Karakasis, Panagiotis Theofilis, Eleftheria Lefkou, Antonios P. Antoniadis, Dimitrios Patoulias, Panagiotis Korantzopoulos, Nikolaos Fragakis
International Journal of Molecular Sciences.2025; 26(6): 2739. CrossRef
Therapeutic effects and mechanistic insights of YiQiHuangDou decoction on high-fat diet-induced obesity-related Glomerulopathy (ORG) in mice
Xiaoxiao Liu, Longfei Zhang, Mingze Xu, Ning Li, Canfeng Bian, Linlin Hu, Wenlong Ma, Dawei Chen, Tianzhu Guan, Lixia Xiao
Journal of Functional Foods.2025; 127: 106728. CrossRef
Targeting Diabetic Atherosclerosis: The Role of GLP-1 Receptor Agonists, SGLT2 Inhibitors, and Nonsteroidal Mineralocorticoid Receptor Antagonists in Vascular Protection and Disease Modulation
Merita Rroji, Nereida Spahia, Andreja Figurek, Goce Spasovski
Biomedicines.2025; 13(3): 728. CrossRef
Atrial Cardiomyopathy in Atrial Fibrillation: Mechanistic Pathways and Emerging Treatment Concepts
Paschalis Karakasis, Panagiotis Theofilis, Panayotis K. Vlachakis, Nikolaos Ktenopoulos, Dimitrios Patoulias, Antonios P. Antoniadis, Nikolaos Fragakis
Journal of Clinical Medicine.2025; 14(9): 3250. CrossRef
Imo-induced changes in gut hormones and glucose metabolism: A key to improving insulin sensitivity in type 2 diabetes
Sobia Naseem, Muhammad Rizwan
Diabetes Research and Clinical Practice.2025; 226: 112285. CrossRef
Atrial Fibrillation in Diabetes: Pathogenesis and Targeted Rhythm Control Strategies
Konstantinos Grigoriou, Paschalis Karakasis, Konstantinos Pamporis, Panagiotis Theofilis, Dimitrios Patoulias, Efstratios Karagiannidis, Barbara Fyntanidou, Antonios P. Antoniadis, Nikolaos Fragakis
Current Issues in Molecular Biology.2025; 47(7): 559. CrossRef
Research progress on the role of FGF21 in insulin resistance
Haixin Zhang, Rongyu Zhu, Quanhao Sun, Likun Du
Frontiers in Endocrinology.2025;[Epub] CrossRef
Comprehensive phytochemical mapping and biomedical evaluation of Lawsonia inermis L: a potential natural treatment for diabetic foot ulcers with wound healing and antimicrobial effects
Safaa M. Kotb, Mai M. Farid, Ahmed A. Al-Karmalawy, Magdy A.H. Zahran, Briksam S. Mohamed, Abdelnaser A. Gadallah, Bishoy El-Aarag
Fitoterapia.2025; 187: 106939. CrossRef
Arrhythmia-Induced Cardiomyopathy in Atrial Fibrillation: Pathogenesis, Diagnosis, and Treatment
Paschalis Karakasis, Panagiotis Theofilis, Panayotis K. Vlachakis, Anastasios Apostolos, Nikolaos Ktenopoulos, Konstantinos Grigoriou, Dimitrios Patoulias, Antonios P. Antoniadis, Nikolaos Fragakis
Life.2025; 15(11): 1675. CrossRef
Current status and future perspectives of FGF21 analogues in clinical trials
Zara Siu Wa Chui, Qing Shen, Aimin Xu
Trends in Endocrinology & Metabolism.2024; 35(5): 371. CrossRef
Hepatokines and MASLD: The GLP1-Ras-FGF21-Fetuin-A Crosstalk as a Therapeutic Target
Ilaria Milani, Michela Codini, Gloria Guarisco, Marianna Chinucci, Chiara Gaita, Frida Leonetti, Danila Capoccia
International Journal of Molecular Sciences.2024; 25(19): 10795. CrossRef
Atrial Fibrosis in Atrial Fibrillation: Mechanistic Insights, Diagnostic Challenges, and Emerging Therapeutic Targets
Paschalis Karakasis, Panagiotis Theofilis, Panayotis K. Vlachakis, Panagiotis Korantzopoulos, Dimitrios Patoulias, Antonios P. Antoniadis, Nikolaos Fragakis
International Journal of Molecular Sciences.2024; 26(1): 209. CrossRef
Design and pharmaceutical evaluation of bifunctional fusion protein of FGF21 and GLP-1 in the treatment of nonalcoholic steatohepatitis
Xianlong Ye, Yingli Chen, Jianying Qi, Shenglong Zhu, Yuanyuan Wu, Jingjing Xiong, Fei Hu, Zhimou Guo, Xinmiao Liang
European Journal of Pharmacology.2023; 952: 175811. CrossRef
Use of FGF21 analogs for the treatment of metabolic disorders: a systematic review and meta-analysis
Maria Paula Carbonetti, Fernanda Almeida-Oliveira, David Majerowicz
Archives of Endocrinology and Metabolism.2023;[Epub] CrossRef
Exploring the potential mechanism of Simiao Yongan decoction in the treatment of diabetic peripheral vascular disease based on network pharmacology and molecular docking technology
Fang Cao, Yongkang Zhang, Yuan Zong, Xia Feng, Junlin Deng, Yuzhen Wang, Yemin Cao
Medicine.2023; 102(52): e36762. CrossRef
The Healing Capability of Clove Flower Extract (CFE) in Streptozotocin-Induced (STZ-Induced) Diabetic Rat Wounds Infected with Multidrug Resistant Bacteria
Rewaa Ali, Tarek Khamis, Gamal Enan, Gamal El-Didamony, Basel Sitohy, Gamal Abdel-Fattah
Molecules.2022; 27(7): 2270. CrossRef
Nonalcoholic Steatohepatitis (NASH) and Atherosclerosis: Explaining Their Pathophysiology, Association and the Role of Incretin-Based Drugs
Eleftheria Galatou, Elena Mourelatou, Sophia Hatziantoniou, Ioannis S. Vizirianakis
Antioxidants.2022; 11(6): 1060. CrossRef
Unlocking the Therapeutic Potential of Glucagon-Like Peptide-1 Analogue and Fibroblast Growth Factor 21 Combination for the Pathogenesis of Atherosclerosis in Type 2 Diabetes
Jang Won Son
Endocrinology and Metabolism.2021; 36(1): 57. CrossRef
Effects of fasting on skeletal muscles and body fat of adult and old C57BL/6J mice
Mindaugas Kvedaras, Petras Minderis, Leonardo Cesanelli, Agne Cekanauskaite, Aivaras Ratkevicius
Experimental Gerontology.2021; 152: 111474. CrossRef
The Role of Fibroblast Growth Factor 21 in Diabetic Cardiovascular Complications and Related Epigenetic Mechanisms
Mengjie Xiao, Yufeng Tang, Shudong Wang, Jie Wang, Jie Wang, Yuanfang Guo, Jingjing Zhang, Junlian Gu
Frontiers in Endocrinology.2021;[Epub] CrossRef
Liraglutide Decreases Liver Fat Content and Serum Fibroblast Growth Factor 21 Levels in Newly Diagnosed Overweight Patients with Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
Xinyue Li, Xiaojuan Wu, Yumei Jia, Jing Fu, Lin Zhang, Tao Jiang, Jia Liu, Guang Wang, Claudia Cardoso
Journal of Diabetes Research.2021; 2021: 1. CrossRef
Differential importance of endothelial and hematopoietic cell GLP-1Rs for cardiometabolic versus hepatic actions of semaglutide
Brent A. McLean, Chi Kin Wong, Kiran Deep Kaur, Randy J. Seeley, Daniel J. Drucker
JCI Insight.2021;[Epub] CrossRef

First
Prev
Page of 1
Next
Last

Search